These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 7506543)
1. Monoclonal antibodies against heparin-binding growth factor-1: neutralization of biological activity and recognition of specific amino acid sequence. Myoken Y; Kan M; Chen J; McKeehan WL; Sato GH; Sato JD Biochem Biophys Res Commun; 1993 Dec; 197(3):1450-7. PubMed ID: 7506543 [TBL] [Abstract][Full Text] [Related]
2. Recovery of mitogenic activity of a growth factor mutant with a nuclear translocation sequence. Imamura T; Engleka K; Zhan X; Tokita Y; Forough R; Roeder D; Jackson A; Maier JA; Hla T; Maciag T Science; 1990 Sep; 249(4976):1567-70. PubMed ID: 1699274 [TBL] [Abstract][Full Text] [Related]
3. Identification of a heparin-binding growth factor-1 nuclear translocation sequence by deletion mutation analysis. Imamura T; Tokita Y; Mitsui Y J Biol Chem; 1992 Mar; 267(8):5676-9. PubMed ID: 1372009 [TBL] [Abstract][Full Text] [Related]
4. Possible dissociation of the heparin-binding and mitogenic activities of heparin-binding (acidic fibroblast) growth factor-1 from its receptor-binding activities by site-directed mutagenesis of a single lysine residue. Burgess WH; Shaheen AM; Ravera M; Jaye M; Donohue PJ; Winkles JA J Cell Biol; 1990 Nov; 111(5 Pt 1):2129-38. PubMed ID: 1699952 [TBL] [Abstract][Full Text] [Related]
5. Potentiation of the activity of mouse liver-derived HBGF-1-like growth factor by heparin and dithiothreitol: evidence for the involvement of a plasma factor. Nagasaki T; Lieberman MA Biochim Biophys Acta; 1991 Sep; 1094(3):330-8. PubMed ID: 1716989 [TBL] [Abstract][Full Text] [Related]
6. Fibronectin, not laminin, mediates heparin-dependent heparin-binding growth factor type I binding to substrata and stimulation of endothelial cell growth. Kan M; Shi EG In Vitro Cell Dev Biol; 1990 Dec; 26(12):1151-6. PubMed ID: 1706698 [TBL] [Abstract][Full Text] [Related]
9. Ability of different chemically modified heparins to potentiate the biological activity of heparin-binding growth factor 1: lack of correlation with growth factor binding. Belford DA; Hendry IA; Parish CR Biochemistry; 1992 Jul; 31(28):6498-503. PubMed ID: 1378755 [TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies against heparin-binding growth factor II/basic fibroblast growth factor that block its biological activity: invalidity of the antibodies for tumor angiogenesis. Matsuzaki K; Yoshitake Y; Matuo Y; Sasaki H; Nishikawa K Proc Natl Acad Sci U S A; 1989 Dec; 86(24):9911-5. PubMed ID: 2481318 [TBL] [Abstract][Full Text] [Related]
11. Bifunctional effects of transforming growth factor-beta (TGF-beta) on endothelial cell growth correlate with phenotypes of TGF-beta binding sites. Myoken Y; Kan M; Sato GH; McKeehan WL; Sato JD Exp Cell Res; 1990 Dec; 191(2):299-304. PubMed ID: 1701723 [TBL] [Abstract][Full Text] [Related]
12. Internalization and degradation of heparin binding growth factor-I by endothelial cells. Friesel R; Maciag T Biochem Biophys Res Commun; 1988 Mar; 151(3):957-64. PubMed ID: 2451523 [TBL] [Abstract][Full Text] [Related]
13. High and low affinity binding of heparin-binding growth factor to a 130-kDa receptor correlates with stimulation and inhibition of growth of a differentiated human hepatoma cell. Kan M; DiSorbo D; Hou JZ; Hoshi H; Mansson PE; McKeehan WL J Biol Chem; 1988 Aug; 263(23):11306-13. PubMed ID: 2457020 [TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of a macrophage-derived heparin-binding growth factor. Besner G; Higashiyama S; Klagsbrun M Cell Regul; 1990 Oct; 1(11):811-9. PubMed ID: 2088527 [TBL] [Abstract][Full Text] [Related]
15. Production of heparin-binding angiogenic factor(s) by bovine corpora lutea during pregnancy. Grazul-Bilska AT; Reynolds LP; Slanger WD; Redmer DA J Anim Sci; 1992 Jan; 70(1):254-62. PubMed ID: 1374752 [TBL] [Abstract][Full Text] [Related]
16. Serum, phorbol ester, and polypeptide mitogens increase class 1 and 2 heparin-binding (acidic and basic fibroblast) growth factor gene expression in human vascular smooth muscle cells. Winkles JA; Gay CG Cell Growth Differ; 1991 Nov; 2(11):531-40. PubMed ID: 1726053 [TBL] [Abstract][Full Text] [Related]
17. Vascular development and heparin-binding growth factors in the bovine corpus luteum at several stages of the estrous cycle. Zheng J; Redmer DA; Reynolds LP Biol Reprod; 1993 Dec; 49(6):1177-89. PubMed ID: 7506941 [TBL] [Abstract][Full Text] [Related]
18. Heparin-binding growth factor-I (endothelial cell growth factor) binds to endothelium in vivo. Rosengart TK; Kupferschmid JP; Ferrans VJ; Casscells W; Maciag T; Clark RE J Vasc Surg; 1988 Feb; 7(2):311-7. PubMed ID: 2448501 [TBL] [Abstract][Full Text] [Related]
19. Heparin protects heparin-binding growth factor-I from proteolytic inactivation in vitro. Rosengart TK; Johnson WV; Friesel R; Clark R; Maciag T Biochem Biophys Res Commun; 1988 Apr; 152(1):432-40. PubMed ID: 2451918 [TBL] [Abstract][Full Text] [Related]
20. Human vascular smooth muscle cells both express and respond to heparin-binding growth factor I (endothelial cell growth factor). Winkles JA; Friesel R; Burgess WH; Howk R; Mehlman T; Weinstein R; Maciag T Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7124-8. PubMed ID: 2444975 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]